earnings

Rite Aid’s Q2 sales and earnings top projections

Rite Aid’s Q2 sales and earnings top projections

CAMP HILL, Pa. — Rite Aid’s second quarter sales and earnings beat Wall Street’s forecast. Adjusted earnings per share of 25 cents topped analysts’ projection of a 1 cent loss.  Revenue for the period ended August 29 climbed 11.5% to $5.98 billion, driven by store and PBM gains, and bettering the forecast $5.75 billion. The

Strong sales propel CVS’ Q1 earnings

Strong sales propel CVS’ Q1 earnings

WOONSOCKET, R.I. — Strong sales during the early stage of the coronavirus pandemic helped lift CVS Health’s first quarter earnings well above Wall Street’s projection. The company’s adjusted earnings per share of $1.91 easily topped analysts’ prediction of $1.63. The comparison is skewed however, by the inability of forecasters to have projected the extent of

Albertsons Cos.’ third quarter earnings jump 51%

Albertsons Cos.’ third quarter earnings jump 51%

BOISE, Idaho — Albertsons Cos.’ third quarter adjusted EBITDA rose 51.4% to $649.7 million, driven by an identical-store sales gain, increased gross profit and cost cutting. Sales and other revenue in the 12 weeks ended December 1 increased 1.8% from a year earlier to $13.8 billion, with identical-store sales rising 1.9%. “We continue to gain traction

CVS sales, earnings top Wall Street estimates

CVS sales, earnings top Wall Street estimates

WOONSOCKET, R.I. — Pharmacy gains propelled CVS Health’s second quarter results ahead of Wall Street’s expectations. Retail sales for the three months ended June 30 climbed 5.7% to $20.7 billion, despite less front-end traffic. Overall same-store sales rose 5.9%. Pharmacy sales jumped 8.3% from a year ago, while same-store front-end sales dipped 1%. CVS’ revenue advanced

Fred’s looks to sell specialty pharmacy business

Fred’s looks to sell specialty pharmacy business

MEMPHIS — Fred’s Inc. has announced plans to sell its specialty pharmacy business. The disclosure led the company to delay publication of its fourth quarter and 2017 full-year results. An earnings call that was slated for today is now expected to be held May 4. A filing yesterday with the Securities and Exchange Commission says